Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int Dent J ; 2024 Jun 23.
Article in English | MEDLINE | ID: mdl-38914506

ABSTRACT

BACKGROUND AND PURPOSE: Long noncoding RNA (lncRNA) dysregulation has been reported to play a pivotal role in the development of cancers. In this study, we aimed to screen the key lncRNA in oral squamous cell carcinoma (OSCC) via bioinformatics analysis and further validate the function of lncRNA in vitro and in vivo. METHODS: Bioinformatics analysis was conducted to identify differentially expressed lncRNAs between control and OSCC samples. Quantitative real-time-polymerase chain reaction was employed to detect the expression of differentially expressed lncRNAs in human tongue squamous cell carcinoma and human oral keratinocytes cell lines. The biological function of lncRNA and its mechanism were examined via the experimental assessment of the cell lines with the lncRNA overexpressed and silenced. Additionally, to further explore the function of lncRNA in the progression of OSCC, xenograft tumour mouse models were established using 25 mice (5 groups, each with 5 mice). Tumour formation was observed at 2 weeks after the cell injection, and the tumours were resected at 5 weeks post-implantation. RESULTS: Two lncRNAs, LINC00958 and AFAP1-AS1, were found to be correlated with the prognosis of OSCC. The results of the quantitative real-time-polymerase chain reaction indicated that the 2 lncRNAs were highly expressed in OSCC. In combination with the previous literature, we found AFAP1-AS1 to be a potentially important biomarker for OSCC. Thus, we further investigated its biological function and found that AFAP1-AS1 silencing inhibited cell proliferation, migration, and invasion whereas AFAP1-AS1 overexpression reversed the effect of AFAP1-AS1 silencing (P < .05). Mechanism analysis revealed that AFAP1-AS1 regulated the development of OSCC through the ubiquitin-mediated proteolysis pathway. CONCLUSIONS: AFAP1-AS1 is an oncogene that aggravates the development of OSCC via the ubiquitin-mediated proteolysis pathway. It also provides a novel potential therapy for OSCC.

2.
Genet Test Mol Biomarkers ; 20(6): 297-303, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27167580

ABSTRACT

OBJECTIVE: To examine the associations of methionine synthase (MTR), methionine synthase reductase (MTRR), and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms with the susceptibility to nonsyndromic cleft lip with or without cleft palate (NSCL/P). METHODS: Between May 2012 and August 2014, 147 NSCL/P patients (case group) and 129 healthy volunteers (control group) were recruited for the study. The MTR A2756G, MTRR A66G, MTHFR C677T and MTHFR A1298C polymorphisms were assessed by polymerase chain reaction-restriction fragment length polymorphism. Haplotype analyses were performed with SHEsis software. Logistic regression analysis was used to evaluate the possible risk factors for NSCL/P. Generalized multifactor dimensionality reduction (GMDR) was applied to detect gene-gene interactions. RESULTS: MTR A2756G, MTRR A66G, and MTHFR C677T gene polymorphisms were associated with the risk of NSCL/P (all p < 0.05). Logistic regression analysis revealed that MTR A2756G, MTR RA66G, and MTHFR C667T might increase the risk of NSCL/P (odds ratio [OR] = 0.270, 95% confidence interval [95% CI] = 0.106-0.689; OR = 0.159, 95% CI = 0.069-0.368; OR = 0.343, 95% CI = 0.139-0.844). The CA haplotype in the MTHFR gene may serve as a protective factor for NSCL/P (OR = 0.658, 95% CI = 0.470-0.923), and the TA haplotype might be a risk factor (OR = 2.001, 95% CI = 1.301-3.077). GMDR revealed that the optimal models were two- and four-dimensional models with prediction accuracies of 75.73% (p = 0.001) and 77.21% (p = 0.001) and the best cross-validation consistencies of 10/10 and 10/10, respectively. CONCLUSION: MTR A2756G, MTRR A66G, and MTHFR C677T polymorphisms may be related to NSCL/P, and interactions were detected between the MTR A2756G, MTRR A66G, and MTHFR C677T and A1298C polymorphisms.


Subject(s)
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics , Cleft Lip/genetics , Cleft Palate/genetics , Ferredoxin-NADP Reductase/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/metabolism , Adolescent , Case-Control Studies , Child , Cleft Lip/enzymology , Cleft Palate/enzymology , Female , Ferredoxin-NADP Reductase/metabolism , Genetic Association Studies , Genetic Predisposition to Disease , Haplotypes , Humans , Male , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , Polymorphism, Single Nucleotide , Risk Factors
3.
Biomed Res Int ; 2013: 218543, 2013.
Article in English | MEDLINE | ID: mdl-23762828

ABSTRACT

The easily accessible mesenchymal stem cells in the Wharton's jelly of human umbilical cord tissue (hUCMSCs) have excellent proliferation and differentiation potential, but it remains unclear whether hUCMSCs can differentiate into odontoblasts. In this study, mesenchymal stem cells were isolated from the Wharton's jelly of human umbilical cord tissue using the simple method of tissue blocks culture attachment. UCMSC surface marker expression was then evaluated for the isolated cells using flow cytometry. The third-passage hUCMSCs induced by conditioned medium from developing tooth germ cells (TGC-CM) displayed high alkaline phosphatase (ALP) levels (P < 0.001), an enhanced ability to proliferate (P < 0.05), and the presence of mineralized nodules. These effects were not observed in cells treated with regular medium. After induction of hUCMSCs, the results of reverse transcriptional polymerase chain reaction (PCR) indicated that the dentin sialophosphoprotein (DSPP) and dentin matrix protein 1 (DMP1) genes were significantly tested. Additionally, dentin sialoprotein (DSP) and DMP1 demonstrated significant levels of staining in an immunofluorescence analysis. In contrast, the control cells failed to display the characteristics of odontoblasts. Taken together, these results suggest that hUCMSCs can be induced to differentiate into odontoblast-like cells with TGC-CM and provide a novel strategy for tooth regeneration research.


Subject(s)
Cell Differentiation/drug effects , Culture Media, Conditioned/pharmacology , Mesenchymal Stem Cells/cytology , Odontoblasts/cytology , Tooth Germ/cytology , Umbilical Cord/cytology , Alkaline Phosphatase/metabolism , Calcification, Physiologic/drug effects , Cell Adhesion/drug effects , Cell Cycle/drug effects , Cell Separation , Cell Shape/drug effects , Humans , Infant, Newborn , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/enzymology , Odontoblasts/drug effects , Odontoblasts/metabolism , Odontogenesis/drug effects
4.
Acta Odontol Scand ; 71(1): 9-14, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22251131

ABSTRACT

OBJECTIVE: To test the hypothesis that T-type voltage-dependent calcium channels (T-CaCNs) are involved in basic fibroblast growth factor (bFGF)-induced proliferation of human periodontal ligament fibroblasts (HPLFs). MATERIALS AND METHODS: This study examined the expression of the T-type calcium channel sub-units Ca(V) 3.1, Ca(V) 3.2 and Ca(V) 3.3 in HPLFs by real-time PCR. Mibefradil, a T-CaCNs antagonist, was used to block the effect of T-CaCNs and the proliferation of HPLFs was evaluated by the water-soluble tetrazolium (WST) assay. The level of intracellular calcium was measured by laser confocal microscopy. RESULTS: Expression of the three subunits of T-CaCNs in HPLFs was detected, which was strongly up-regulated upon stimulation by bFGF. The proliferation of HPLFs induced by bFGF was decreased significantly by treatment with Mibefradil. This effect was associated with the decreased expression of T-CaCNs and a decreased level of intracellular calcium. CONCLUSIONS: Expression of the T-CaCNs affected the proliferation of HPLFs that was induced by bFGF, indicating that T-CaCNs could be important in mediating periodontal ligament (PDL) remodeling.


Subject(s)
Calcium Channels, T-Type/biosynthesis , Calcium Channels, T-Type/physiology , Cell Proliferation/drug effects , Fibroblast Growth Factor 2/pharmacology , Periodontal Ligament/cytology , Analysis of Variance , Calcium/analysis , Calcium Channel Blockers/pharmacology , Cells, Cultured , Fibroblast Growth Factor 2/antagonists & inhibitors , Fibroblasts/cytology , Fibroblasts/physiology , Humans , Mibefradil/pharmacology , Microscopy, Confocal , Periodontal Ligament/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...